Status:
COMPLETED
A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Healthy Volunteers
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to characterize the absorption, distribution, metabolism and excretion (ADME) of a single oral dose of \[14C\] CC-99677.
Eligibility Criteria
Inclusion
- Healthy male participants
- Body mass index of 18.0 to 33.0 kg/m\^2, inclusive
Exclusion
- Any significant acute or chronic medical illness
- Any major surgery within 4 weeks of intervention administration
- History of any significant drug allergy
- Other protocol-defined inclusion/exclusion criteria apply
Key Trial Info
Start Date :
May 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05284890
Start Date
May 12 2022
End Date
July 11 2022
Last Update
December 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution - 0001
Madison, Wisconsin, United States, 53704-2526